New Arrivals/Restock

PRACTICAL MANUAL FOR ANTI-AMYLOID THERAPY IN CLINICAL PRACTICE: A Comprehensive Clinical Guide for Healthcare Providers (Clinical Masterclass)

flash sale iconLimited Time Sale
Until the end
19
11
55

US$29.97 cheaper than the new price!!

Free shipping for purchases over $99 ( Details )
Free cash-on-delivery fees for purchases over $99
Please note that the sales price and tax displayed may differ between online and in-store. Also, the product may be out of stock in-store.
Used  US$19.98
quantity

Product details

Management number 222232263 Release Date 2026/05/04 List Price US$19.98 Model Number 222232263
Category

A Practical Manual for Anti-Amyloid Therapy in Clinical PracticeThe definitive clinical guide for implementing disease-modifying Alzheimer's treatmentsThe FDA approval of lecanemab (LEQEMBI®) and donanemab (KISUNLA®) has ushered in a new era of Alzheimer's disease treatment—but translating groundbreaking science into safe, effective clinical care requires practical guidance that didn't exist. Until now.A Practical Manual for Anti-Amyloid Therapy in Clinical Practice is the comprehensive, evidence-based resource that neurologists, dementia specialists, and multidisciplinary care teams need to confidently implement anti-amyloid immunotherapy programs.WHAT'S INSIDE:Patient Selection Made Clear — Step-by-step eligibility criteria, contraindications, and the critical role of APOE genotyping in risk stratificationARIA Mastery — Complete protocols for monitoring, detecting, grading, and managing amyloid-related imaging abnormalities, the most significant safety consideration in anti-amyloid therapyDrug-Specific Protocols — Side-by-side comparison of lecanemab and donanemab dosing, infusion procedures, MRI surveillance schedules, and treatment duration strategiesReal-World Clinical Scenarios — Practical guidance for anticoagulation management, atrial fibrillation, post-ARIA rechallenge decisions, and transitioning between therapiesRegulatory Compliance — CMS registry requirements, Medicare coverage criteria, quality metrics, and documentation standards for audit readinessReady-to-Use Tools — Quick-reference pocket cards, EHR-ready order sets, patient education materials, and informed consent frameworksFULLY UPDATED FOR 2026:FDA-cleared plasma p-tau217 blood biomarker testingSubcutaneous lecanemab (LEQEMBI IQLIK™) maintenance dosingPipeline therapies including trontinemab and remternetugLatest ARIA management recommendations and real-world safety dataWHO THIS BOOK IS FOR:Neurologists and dementia specialists initiating anti-amyloid therapy programsBehavioral Neurology & Neuropsychiatry fellows in trainingNurse practitioners and physician assistants in memory careInfusion center nurses and radiology teamsMemory clinic administrators building treatment infrastructureFROM THE FRONT LINES OF ALZHEIMER'S CARE:Developed at a leading Alzheimer's Disease Research Center with real-world clinical experience, this manual bridges the gap between pivotal trial data and the practical realities of treating patients in your clinic.Whether you're launching a new anti-amyloid therapy program or optimizing an existing one, this manual provides the protocols, checklists, and clinical pearls you need to deliver safe, effective, patient-centered care. Read more

ISBN13 979-8246408094
Language English
Publisher Independently published
Dimensions 5 x 0.36 x 8 inches
Book 1 of 1 Clinical Masterclass
Item Weight 8 ounces
Print length 151 pages
Publication date March 2, 2026

Correction of product information

If you notice any omissions or errors in the product information on this page, please use the correction request form below.

Correction Request Form

Product Review

You must be logged in to post a review